Our previous studies also showed that combining CSII with insulin sensitizers, that is, metformin or rosiglitazone, increases short-term remission rate by improving both insulin sensitivity and beta cell function patients with newly diagnosed T2DM. Here, INS is linked to type 2 diabetes mellitus.